MBX Biosciences, Inc. Common Stock (MBX) Earnings Analysis
MBX Biosciences, Inc. Common Stock (MBX) next reports earnings on 2026-08-06, consensus EPS -0.68 USD. Last quarter (2026-05-07) it beat with EPS -0.51 USD vs -0.62 USD est (+17.7%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E -26.50.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MBX next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.68 USD |
| Revenue estimate | n/a |
MBX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.51 USD | -0.62 USD | +17.7% | Beat |
| 2026-03-12 | -0.49 USD | -0.64 USD | +23.4% | Beat |
| 2025-11-06 | -0.63 USD | -0.73 USD | +13.7% | Beat |
| 2025-08-07 | -0.58 USD | -0.77 USD | +24.7% | Beat |
| 2025-05-12 | -0.71 USD | -0.81 USD | +12.3% | Beat |
| 2025-03-17 | -0.47 USD | -0.59 USD | +20.3% | Beat |
| 2024-11-07 | -2.78 USD | -2.72 USD | -2.2% | Miss |
| 2024-08-23 | -11.47 USD | n/a | n/a | n/a |
Beat rate: 6/7 (86%) over reported quarters with consensus data.
MBX valuation and analyst view
| Trailing P/E | -26.50 |
|---|---|
| Trailing EPS | -1.85949 USD |
| Price / book | 6.20 |
| Dividend yield | 0.00% |
| Market cap | 1.93B |
| Analyst consensus | Buy (7 buy / 0 hold / 0 sell) |
| Avg price target | 71.5 USD |
Related research pages
Frequently asked questions
When is MBX Biosciences, Inc. Common Stock (MBX)'s next earnings date?
MBX Biosciences, Inc. Common Stock is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.68 USD.
Did MBX beat earnings last quarter?
In its 2026-05-07 report, MBX posted EPS of -0.51 USD versus a -0.62 USD estimate — a beat of 17.7%.
What is MBX's earnings track record?
Over the last 7 reported quarters with consensus data, MBX beat estimates 6 times (86%).
What is MBX's current P/E ratio and EPS?
MBX trades at a trailing P/E of -26.50 on trailing EPS of -1.859490309686895 USD.
What do analysts rate MBX?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 71.5 USD.